# Larimar Therapeutics (stock symbol: LRMR) Logo in transparent PNG format

## Larimar Therapeutics Logo large

### Larimar Therapeutics Logo large Download PNG (178.93 KB)

![Larimar Therapeutics Logo large Download PNG (178.93 KB)](/img/orig/LRMR_BIG-2b8a8582.png)

## Larimar Therapeutics Logo icon format

### Larimar Therapeutics Logo icon format Download PNG (11.45 KB)

![Larimar Therapeutics Logo icon format Download PNG (11.45 KB)](/img/orig/LRMR-4b089ebd.png)

## Larimar Therapeutics Logo large for dark backgrounds

### Larimar Therapeutics Logo large for dark backgrounds Download PNG (167.08 KB)

![Larimar Therapeutics Logo large for dark backgrounds Download PNG (167.08 KB)](/img/orig/LRMR_BIG.D-de1d573e.png)

## Larimar Therapeutics Logo icon format for dark backgrounds

### Larimar Therapeutics Logo icon format for dark backgrounds Download PNG (6.16 KB)

![Larimar Therapeutics Logo icon format for dark backgrounds Download PNG (6.16 KB)](/img/orig/LRMR.D-b10cacf1.png)

## About Larimar Therapeutics

Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 1 clinical trial for the treatment of Friedreich's ataxia, a rare, progressive, and fatal genetic disease. The company is based in Bala Cynwyd, Pennsylvania.

1. Website domain: larimartx.com
2. Employees: 31
3. Marketcap: $0.20 Billion USD


## Categories
- [x] ðŸ‡ºðŸ‡¸ United States
- [x] ðŸ’Š Pharmaceuticals
- [x] ðŸ§¬ Biotech
